Parkinson’s Disease drug sales to nearly double by 2025.
Datamonitor Healthcare estimates that Parkinson’s disease sales will grow substantially in the US, Japan, and five major EU markets, expanding from $3.2bn in 2016 to $6.0bn in 2025.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: